rs2651899 — PRDM16

PRDM16 — Where Migraine Meets Metabolic Fire

PRDM16 (PR/SET Domain 16) is best known as the master transcription factor that drives brown and beige fat cell differentiation — the type of fat that burns calories to produce heat rather than storing them. But a landmark genome-wide association study unexpectedly placed this metabolic gene at the center of migraine biology, revealing a surprising link between thermogenic fat regulation and headache susceptibility.

The Mechanism

The rs2651899 variant sits within the first intron of PRDM16 in a region of moderate linkage disequilibrium¹¹ linkage disequilibrium
LD — the tendency of nearby genetic variants to be inherited together because they sit close on the same chromosome extending roughly 22 kb in each direction. While intronic, this region likely harbors regulatory elements that influence PRDM16 expression levels. PRDM16 protein acts as a transcriptional switch: it activates the thermogenic gene program (including UCP1) in adipocytes and simultaneously represses white fat and smooth muscle gene programs. In the vascular system, PRDM16 maintains beige adipocyte identity in perivascular fat — the fat cushion surrounding blood vessels that modulates vascular tone.

The migraine connection, while not fully resolved, likely involves PRDM16's role in neurovascular regulation. A 2026 study in Science²² 2026 study in Science
Cohen et al. Ablation of Prdm16 and beige fat identity causes vascular remodeling and elevated blood pressure demonstrated that when PRDM16 is lost in adipocytes, beige fat converts to dysfunctional white fat that overproduces the enzyme QSOX1³³ QSOX1
Quiescin sulfhydryl oxidase 1 — an enzyme that promotes collagen cross-linking and tissue fibrosis, triggering vascular fibrosis, increased vascular reactivity, and hypertension. In human cohorts, carriers of PRDM16 mutations showed elevated blood pressure, confirming the mouse findings translate to human biology.

The Evidence

The original GWAS⁴⁴ original GWAS
Chasman et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet, 2011 analyzed 5,122 migraineurs and 18,108 controls from the Women's Genome Health Study, identifying rs2651899 with an odds ratio of 1.11 (95% CI 1.07-1.15, p = 3.8 x 10⁻⁹) — reaching genome-wide significance. This was replicated across three independent cohorts totaling 3,828 additional migraineurs.

A meta-analysis of eight studies⁵⁵ meta-analysis of eight studies
Kowalska et al. Deciphering the role of rs2651899, rs10166942, and rs11172113 polymorphisms in migraine. Medicina, 2022 including 2,320 migraine patients and 2,615 controls found the CC genotype associated with overall migraine risk (OR = 1.32, 95% CI 1.02-1.73) and a stronger effect for migraine with aura (OR = 1.40, 95% CI 1.12-1.74, p = 0.003). A separate meta-analysis⁶⁶ separate meta-analysis
Lee et al. Association of rs2651899 polymorphism in PRDM16 and common migraine subtypes. Headache, 2020 of six studies with 2,853 cases confirmed the recessive model (CC vs CT+TT) showed OR = 1.42 for migraine.

Replication studies in Chinese⁷⁷ Chinese
Zhao et al. PRDM16 rs2651899 variant is a risk factor for Chinese common migraine patients, Indian⁸⁸ Indian, and Pakistani⁹⁹ Pakistani populations have confirmed the association, though with varying effect sizes and migraine subtypes.

Practical Actions

The dual nature of PRDM16 — governing both thermogenic fat and neurovascular function — opens two avenues of action. For migraine susceptibility, mitochondrial-supporting supplements have strong evidence from randomized controlled trials: riboflavin (vitamin B2) at 400 mg/day reduced migraine frequency¹⁰¹⁰ reduced migraine frequency
Schoenen et al. Effectiveness of high-dose riboflavin in migraine prophylaxis. Neurology, 1998 by 50% or more in 59% of treated patients (NNT = 2.3), while CoQ10 supplementation¹¹¹¹ CoQ10 supplementation
Sazali et al. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine. BMJ Open, 2021 reduced attack frequency and duration in meta-analysis. Magnesium (400-600 mg/day as glycinate or threonate) earned a Level B recommendation from the American Headache Society for migraine prevention.

For the thermogenic side, cold exposure protocols (cold showers, outdoor cold exposure) directly stimulate PRDM16-dependent beige fat activation and may help compensate for reduced PRDM16 activity by upregulating thermogenic pathways through sympathetic nervous system signaling.

Interactions

PRDM16 rs2651899 was discovered alongside TRPM8 rs10166942 (a cold-sensing ion channel) in the same migraine GWAS, representing two branches of thermosensory-neurovascular vulnerability. PRDM16 also sits upstream in the same thermogenic cascade as UCP1 (rs1800592) and ADRB3 (rs4994) — variants that independently impair brown/beige fat function. Carrying risk alleles across multiple thermogenic pathway genes could compound both metabolic and neurovascular effects, though direct interaction studies for rs2651899 with these SNPs have not yet been published.